Cost effectiveness of budesonide/formoterol vs fluticasone/salmeterol: Real-world effectiveness and safety in COPD

被引：0
|
作者：
Hedegaard, Morten [1 ]
Janson, Christer [2 ]
Lisspers, Karin [3 ]
Stallberg, Bjorn [3 ]
Johansson, Gunnar [3 ]
Jorgensen, Leif [1 ]
Larssen, Kjell [4 ]
机构：
[1] Astrazeneca, R&D, Sodertalje, Sweden
[2] Uppsala Univ, Dept Med Sci, Resp Med, Uppsala, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Serv Family Med & Prevent, Uppsala, Sweden
[4] Karolinska Inst, Natl Inst Environm Med, Unit Lung & Allergy Res, Stockholm, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
COPD; -; management; Exacerbation; Pneumonia;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1999
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bronchodilator effect of an inhaled combination therapy with salmeterol plus fluticasone and formoterol plus budesonide in patients with COPD
    Cazzola, M
    Santus, P
    Di Marco, F
    Boveri, B
    Castagna, F
    Carlucci, P
    Matera, MG
    Centanni, S
    RESPIRATORY MEDICINE, 2003, 97 (05) : 453 - 457
  • [42] Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
    Price, David
    Small, Iain
    Haughney, John
    Ryan, Dermot
    Gruffydd-Jones, Kevin
    Lavorini, Federico
    Harris, Tim
    Burden, Annie
    Brockman, Jeremy
    King, Christine
    Papis, Alberto
    PRIMARY CARE RESPIRATORY JOURNAL, 2013, 22 (04): : 439 - 448
  • [43] Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation
    Ming, Simon Wan Yau
    Haughney, John
    Small, Iain
    Wolfe, Stephanie
    Hamill, John
    Gruffydd-Jones, Kevin
    Daly, Cathal
    Soriano, Joan B.
    Gardener, Elizabeth
    Skinner, Derek
    d'Alcontres, Martina Stagno
    Price, David B.
    RESPIRATORY MEDICINE, 2017, 129 : 199 - 206
  • [44] Cost Effectiveness of Fluticasone and Budesonide in Patients with Moderate Asthma
    Karl-Otto Steinmetz
    Timm Volmer
    Marion Trautmann
    Adrian Kielhorn
    Clinical Drug Investigation, 1998, 16 : 117 - 123
  • [45] Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
    Voorham, Jaco
    Roche, Nicolas
    Benhaddi, Hicham
    van der Tol, Marianka
    Carter, Victoria
    van Boven, Job F. M.
    Bjermer, Leif
    Miravitlles, Marc
    Price, David B.
    BMJ OPEN, 2018, 8 (10):
  • [46] Cost effectiveness of fluticasone and budesonide in patients with moderate asthma
    Steinmetz, KO
    Volmer, T
    Trautmann, M
    Kielhorn, A
    CLINICAL DRUG INVESTIGATION, 1998, 16 (02) : 117 - 123
  • [47] Effectiveness and Treatment Compliance of Salmeterol-Fluticasone Easyhaler(R) Among Patients with Asthma, COPD, or Asthma-COPD Overlap Syndrome: Real-World Study Findings
    Tamasi, Lilla
    Bartha, Anna
    Ferencz, Aranka
    Timar, Mihaly
    Vahteristo, Mikko
    Takala, Aino
    Muller, Veronika
    PULMONARY THERAPY, 2022, 8 (04) : 369 - 384
  • [48] COST-EFFECTIVENESS ANALYSIS OF THE FIXED COMBINATION INDACATEROL/GLYCOPYRRONIUM VS. TIOTROPIUM AND SALMETEROL/FLUTICASONE IN THE MANAGEMENT OF COPD IN GREECE
    Geitona, M.
    Kousoulakou, H.
    Kalogeropoulou, M.
    Mitsiki, E.
    Panitti, E.
    Steiropoulos, P.
    VALUE IN HEALTH, 2015, 18 (07) : A500 - A500
  • [49] Cost-effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
    Tohda, Yuji
    Nishima, Sankei
    Arakawa, Ichiro
    Shiragami, Makoto
    Miyamoto, Terumasa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (04): : 593 - 603
  • [50] Salmeterol/fluticasone propionate combination product in asthma - An evaluation of its cost effectiveness vs fluticasone propionate - Foreword
    Stempel, DA
    PHARMACOECONOMICS, 1999, 16 : U6 - U7
12345